Summary
Over the counter painkillers like Motrin and Advil have long been considered harmless when taken in the recommended doses. The safety of these painkillers, though, has been called into question by the removal of Bextra and Vioxx, two newer painkillers recently pulled from store shelves due to safety concerns.
A recent study shows that, though taking these over the counter medications can reduce smokers' chances of mouth cancer by half, that benefit is offset by an increased risk of cardiovascular disease. Despite the relatively small size of the study (only 908 people participated), doctors are still concerned by adverse reactions to over the counter painkillers.
Original source:
http://www.usatoday.com/news/health/2005-04-25-painkillers_x.htm
Details
Smokers in Norway who took such drugs for at least six months had twice the risk of dying of a heart attack, stroke or other heart-related problem.
The findings came from a study of whether these pain relievers could prevent oral cancer.
The drugs did, in fact, cut the risk of developing oral cancer in half, but the deaths that were prevented were offset by the increased risk of dying from cardiovascular disease, according to the study, reported Monday at an American Association for Cancer Research conference in Anaheim.
The study was relatively small --- 908 people --- and involved people prone to heart problems and cancer because they smoked.
But specialists said it supports the Food and Drug Administration's recent decision to warn about long-term use of all such painkillers except aspirin.
The findings add to the suspicion that the heart risk extends beyond the so-called cox-2 drugs --- Bextra, Vioxx and Celebrex --- to the larger family of medications known as non-steroidal anti-inflammatory drugs, or NSAIDs, which include naproxen, ibuprofen and virtually all other over-the-counter pain relievers except acetaminophen or Tylenol.
"To the best of our knowledge, these are the first data to support putting a box warning on NSAIDs, not just cox-2s," said Dr. Andrew Dannenberg, a Cornell University scientist who helped do the Norway study.
In other news at the conference, a large study suggested that cholesterol-lowering statin drugs might help prevent the most serious types of prostate cancer --- those that kill or spread throughout the body.
Men who took statins had half the risk of advanced prostate cancer as men who did not take such drugs, reported Elizabeth Platz of Johns Hopkins University, who did the study with Harvard University researchers and the National Cancer Institute.
About the author: Mike Adams is a consumer health advocate and award-winning journalist with a passion for sharing empowering information to help improve personal and planetary health He is a prolific writer and has published thousands of articles, interviews, reports and consumer guides, and he is well known as the creator of popular downloadable preparedness programs on financial collapse, emergency food storage, wilderness survival and home defense skills. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2010, Adams launched TV.NaturalNews.com, a natural health video site featuring videos on holistic health and green living. He also founded an environmentally-friendly online retailer called BetterLifeGoods.com that uses retail profits to help support consumer advocacy programs. He's also a veteran of the software technology industry, having founded a personalized mass email software product used to deliver email newsletters to subscribers. Adams also serves as the executive director of the Consumer Wellness Center, a non-profit consumer protection group, and pursues hobbies such as martial arts, Capoeira, nature macrophotography and organic gardening. Known on the 'net as 'the Health Ranger,' Adams shares his ethics, mission statements and personal health statistics at www.HealthRanger.org
Have comments on this article? Post them here:
people have commented on this article.
Tuesday, May 10, 2005
Email this article to a friend
Share
this article on: 
